Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Immunotherapy. 2011 Oct;3(10):1253-64. doi: 10.2217/imt.11.124.
Advances in tumor biology have demonstrated a point of critical importance: tumor are established as an intersection of malignant clone cells and surrounding stromal cells. The stroma is composed of nonhematopoietic cells, including connective tissue cells, blood vessels, nerves, fat and smooth muscle cells, in the extracellular matrix niche. Recent studies have demonstrated that stromal cells regulate immune responses by: coordinating lymphocyte homing, differentiation, activation and antigen responses; inducing tolerance; and maintaining immunologic memory. Hence, elucidation of the interaction between stromal cells and lymphocytes is essential for generating effective immunotherapies. In this article, we summarize what is currently known about the interactions between stromal cells and lymphocytes in the tumor microenvironment, as well as potential immunotherapeutic approaches targeting stroma-lymphocyte interactions; both in the context of our work on multiple myeloma, and of recent literature in both solid tumors and hematologic malignancies.
肿瘤是恶性克隆细胞和周围基质细胞的交集。基质由非造血细胞组成,包括结缔组织细胞、血管、神经、脂肪和平滑肌细胞,位于细胞外基质龛位中。最近的研究表明,基质细胞通过以下方式调节免疫反应:协调淋巴细胞归巢、分化、激活和抗原反应;诱导耐受;并维持免疫记忆。因此,阐明基质细胞与淋巴细胞之间的相互作用对于产生有效的免疫疗法至关重要。在本文中,我们总结了目前已知的肿瘤微环境中基质细胞与淋巴细胞之间的相互作用,以及针对基质-淋巴细胞相互作用的潜在免疫治疗方法;既包括我们在多发性骨髓瘤方面的工作,也包括实体瘤和血液恶性肿瘤的最新文献。